Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development

Background: A critical step in tuberculosis (TB) drug development is the Phase 2a early bactericidal activity (EBA) study which informs if a new drug or treatment has short-term activity in humans. The aim of this work was to present a standardized pharmacometric model-based early bactericidal activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Mockeliunas, Laurynas, Faraj, Alan, van Wijk, Rob C., Upton, Caryn M., van den Hoogen, Gerben, Diacon, Andreas H., Simonsson, Ulrika S. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133723/
https://www.ncbi.nlm.nih.gov/pubmed/37124198
http://dx.doi.org/10.3389/fphar.2023.1150243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133723/
https://www.ncbi.nlm.nih.gov/pubmed/37124198
http://dx.doi.org/10.3389/fphar.2023.1150243

Ejemplares similares